Role of apoptosis in atherosclerosis and its therapeutic implications

Clinical Science

Volumn 107, Issue 4, 2004, Pages 343-354

  Stoneman, Victoria E A ^a   Bennett, Martin R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Atherogenesis; Growth factor; Inflammation; Oxidative stress; Plaque rupture; Signalling pathway

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; COLLAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROBUCOL; SUPEROXIDE DISMUTASE;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATORY CELL; MACROPHAGE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; UNSTABLE ANGINA PECTORIS; VASCULAR SMOOTH MUSCLE;

ANTIOXIDANTS; APOPTOSIS; ARTERIOSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR;

EID: 6344226512     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040086     Document Type: Review

References (154)

1. Kerr, J. F., Wyllie, A. H. and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide ranging implictions in tissue kinetics. Br. J. Cancer 26, 239-257
2. Saunders, Jr, J. W. (1966) Death in embryonic systems. Science (Washington, D.C.) 154, 604-612
3. Imai, H. and Thomas, W. A. (1968) Cerebral atherosclerosis in swine: role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp. Mol. Pathol. 8, 330-357
4. Wyllie, A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 284, 555-556
5. Degterev, A., Boyce, M. and Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567
6. Wen, L. P., Fahrni, J. A., Troie, S., Guan, J. L., Orth, K. and Rosen, G. D. (1997) Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272, 26056-26061
7. Brancolini, C., Lazarevic, D., Rodriquez, J. and Schneider, C. (1997) Dismantling cell-cell contacts during apoptosis is coupled to caspase-dependent proteolytic cleavage of β-catenin. J. Cell Biol. 139, 759-771
8. Brown, S. B., Bailey, K. and Savill, J. (1997) Actin is cleaved during constitutive apoptosis. Biochem. J. 323, 233-237
9. Leist, M. and Jaattela, M. (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589-598
10. McCarthy, N. J. and Bennett, M. R. (2000) The regulation of vascular smooth muscle cell apoptosis. Cardiovasc. Res. 45, 747-755
11. Schmitz, I., Kirchhoff, S. and Krammer, P. H. (2000) Regulation of death receptor-mediated apoptosis pathways. Int. J. Biochem. Cell. Biol. 32, 1123-1136
12. Vincenz, C. (2001) Death receptors and apoptosis. Deadly signaling and evasive tactics. Cardiol. Clin. 19, 31-43
13. Tnorburn, A. (2004) Death receptor-induced cell killing. Cell Signal. 16, 139-144
14. Ashkenazi, A. and Dixit, V. (1998) Death receptors: signalling and modulation. Science (Washington, D.C.) 281, 1305-1308
15. Zeiher, A. M., Fisslthaler, B., Schray-Utz, B. and Busse, R. (1995) Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76, 980-986
16. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C. et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell (Cambridge, Mass.) 85, 817-827
17. Li, H., Zhu, H., Xu, C. J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (Cambridge, Mass.) 94, 491-501
18. Shimizu, S., Narita, M. and Tsujimoto, Y. (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (London) 399, 483-487
19. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. and Nicotera, P. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486
20. Leist, M., Gantner, F., Jilg, S. and Wendel, A. (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154, 1307-1316
21. Hata, S., Fukuo, K., Morimoto, S., Eguchi, Y., Tsujimoto, Y. and Ogihara, T. (2001) Vascular smooth muscle maintains the levels of Bcl-2 in endothelial cells. Atherosclerosis 154, 309-316
22. Gordon, D., Reidy, M. A., Benditt, E. P. and Schwartz, S. M. (1990) Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U.S.A. 87, 4600-4604
23. Kaplan, M. and Aviram, M. (1999) Oxidized low density lipoprotem: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin. Chem. Lab. Med. 37, 777-787
24. Hubbard, A. K. and Rothlein, R. (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radical Biol. Med. 28, 1379-1386
25. Roebuck, K. A. (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-κB. Int. J. Mol. Med. 4, 223-230
26. Marui, N., Offermann, M. K., Swerlick, R. et al. (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92, 1866-1874
27. Tsouknos, A., Nash, G. B. and Rainger, G. E. (2003) Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells. Atherosclerosis 170, 49-58
28. Lutgens, E., de Muinck, E. D., Kitslaar, P. J., Tordoir, J. H., Wellens, H. J. and Daemen, M. J. (1999) Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc. Res. 41, 473-479
29. Huber, J., Vales, A., Mitulovic, G. et al. (2002) Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler., Thromb., Vasc. Biol. 22, 101-107
30. Cole, A. L., Subbanagounder, G., Mukhopadhyay, S., Berliner, J. A. and Vora, D. K. (2003) Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler., Thromb., Vasc. Biol. 23, 1384-1390
31. Ross, R. (1990) Mechanisms of atherosclerosis: a review. Adv. Nephrol. Necker Hosp. 19, 79-86
32. Dimmeler, S., Hermann, C. and Zeiher, A. M. (1998) Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur. Cytokine Netw. 9, 697-698
33. Fournet-Bourguignon, M. P., Castedo-Delrieu, M., Bidouard, J. P. et al. (2000) Phenotypic and functional changes in regenerated porcine coronary endothelial cells: increased uptake of modified LDL and reduced production of NO. Circ. Res. 86, 854-861
34. Du, X. L., Sui, G. Z., Stockklauser-Farber, K. et al. (1998) Introduction of apoptosis by high pro-insulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia 41, 249-256
35. Kim, J. A., Berliner, J. A., Natarajan, R. D. and Nadler, J. L. (1994) Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43, 1103-1107
36. Schmidt-Ott, K. M., Kagiyama, S. and Phillips, M. I. (2000) The multiple actions of angiotensin II in atherosclerosis. Regul. Pept. 93, 65-77
37. Lizard, G., Monier, S., Cordelet, C. et al. (1999) Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7β-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arteriscler., Thromb., Vasc. Biol. 19, 1190-1200
38. Li, D., Yang, B. and Mehta, J. L. (1998) Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2 and Fas. Am. J. Physiol. 275, H568-H576
39. Galle, J. and Heermeier, K. (1999) Angiotensin II and oxidized LDL: an unholy alliance creating oxidative stress. Nephrol., Dial. Transplant. 14, 2585-2589
40. Urbich, C., Walter, D. H., Zeiher, A. M. and Dimmeler, S. (2000) Laminar shear stress upregulates integrin expression: role in endothelial cell adhesion and apoptosis. Circ. Res. 87, 683-689
41. Ilic, D., Almeida, E. A., Schlaepfer, D. D., Dazin, P., Aizawa, S. and Damsky, C. H. (1998) Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547-560
42. Garcia-Cardena, G., Comander, J., Anderson, K. R., Blackman, B. R. and Gimbrone, Jr, M. A. (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. U.S.A. 98, 4478-4485
43. Levkau, B., Herren, B., Koyama, H., Ross, R. and Raines, E. W. (1998) Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesion in human endothelial cell apoptosis. J. Exp. Med. 187, 579-586
44. Bartling, B., Tostlebe, H., Darmer, D., Holtz, J., Silber, R. E. and Morawietz, H. (2000) Shear stress-dependent expression of apoptosis-regulating genes in endothelial cells. Biochem. Biophys. Res. Commun. 278, 740-746
45. Noris, M., Morigi, M., Donadelli, R. et al. (1995) Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76, 536-543
46. Napoli, C. and Ignarro, L. J. (2001) Nitric oxide and atherosclerosis. Nitric Oxide 5, 88-97
47. Tricot, O., Mallat, Z., Heymes, C., Belmin, J., Leseche, G. and Tedgui, A. (2000) Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101, 2450-2453
48. Mason, C. A., Bigras, J. L., O'Blenes, S. B. et al. (1999a). Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat. Med. 5, 176-182
49. Mason, C. A., Chang, P., Fallery, C. and Rabinovitch, M. (1999) Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation. FASEB J. 13, 1423-1434
50. Michel, J. B. (2003) Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler., Thromb., Vasc. Biol. 23, 2146-2154
51. Coleman, K. R., Braden, G. A., Willingham, M. C. and Sane, D. C. (1999) Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (αvβ3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ. Res. 84, 1268-1276
52. Zachary, I., Mathur, A., Yla-Herttuala, S. and Martin, J. (2000) Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler., Thromb., Vasc. Biol. 20, 1512-1520
53. Gerber, H. P., Dixit, V. and Ferrara, N. (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273, 13313-13316
54. Liu, W., Ahmad, S. A., Reinmuth, N. et al. (2000) Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 5, 323-328
55. Karsan, A., Yee, E., Poirier, G. G., Zhou, P., Craig, R. and Harlan, J. M. (1997) Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am. J. Pathol. 151, 1775-1784
56. Fujikawa, K., de Aos Scherpenseel, I., Jain, S. K., Presman, E., Christensen, R. A. and Varticovski, L. (1999) Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp. Cell. Res. 253, 663-672
57. Bennett, M. R., Evan, G. I. and Schwartz, S. M. (1995) Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res. 77, 266-273
58. Bai, H., Pollman, M. J., Inishi, Y. and Gibbons, G. H. (1999) Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ. Res. 85, 229-237
59. Pollman, M. J., Naumovski, L. and Gibbons, G. H. (1999) Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells. Circulation 99, 2019-2026
60. Li, Y., Higashi, Y., Itabe, H., Song, Y. H., Du, J. and Delafontaine, P. (2003) Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway. Arterioscler., Thromb., Vasc. Biol. 23, 2178-2184
61. Jamali, R., Bao, M. and Arnqvist, H. J. (2003) IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells. J. Endocrinol. 179, 267-274
62. Patel, V. A., Zhang, Q. J., Siddle, K. et al. (2001) Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ. Res. 88, 895-902
63. Scheidegger, K. J., James, R. W. and Delafontaine, P. (2000) Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J. Biol. Chem. 275, 26864-26869
64. Anwar, A., Zahid, A. A., Scheidegger, K. J., Brink, M. and Delafontaine, P. (2002) Tumor necrosis factor-α regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105, 1220-1225
65. Krueger, K. D., Hunter, III, W. J., DelCore, M. G. and Agrawal, D. K. (2003) Calphostin C as a rapid and strong inducer of apoptosis in human coronary artery smooth muscle cells. Int. Immunopharmacol. 3, 1751-1759
66. Kojda, G. and Harrison, D. (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43, 562-571
67. Betteridge, D. J. (2000) What is oxidative stress? Metabolism, Clin. Exp. 49, 3-8
68. Napoli, C., de Nigris, F. and Palinski, W. (2001) Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82, 674-682
69. Abdu, T. A., Elhadd, T., Pfeifer, M. and Clayton, R. N. (2001) Endothelial dysfunction in endocrine disease. Trends Endocrinol. Metab. 12, 257-265
70. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
71. Harrison, D. G., Cai, H., Landmesser, U. and Griendling, K. K. (2003) Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 4, 51-61
72. Wilson, P. W., Garrison, R. J., Castelli, W. P., Feinleib, M., McNamara, P. M. and Kannel, W. B. (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am. J. Cardiol. 46, 649-654
73. Carpenter, K. L., Taylor, S. E., van der Veen, C., Williamson, B. K., Ballantine, J. A. and Mitchinson, M. J. (1995) Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim. Biophys. Acta 1256, 141-150
74. Waddington, E., Sienuarine, K., Puddey, I. and Croft, K. (2001) Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal. Biochem. 292, 234-244
75. Napoli, C., Quehenberger, O., De Nigris, F., Abete, P., Glass, C. K. and Palinski, W (2000) Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14, 1996-2007
76. Aviram, M. (2000) Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radical Res. 33 (Suppl.), S85-S97
77. Rusinol, A. E., Thewke, D., Liu, J., Freeman, N., Panini, S. R. and Sinensky, M. S. (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J. Biol. Chem. 279, 1392-1399
78. Dimmeler, S., Hermann, C. and Mondorf, U. (1999) Pro-atherosclerotic factors induce the dephosphorylation of the survival signalling protein kinase Akt. Circulation 100 (suppl. 1), 1
79. Hermann, C., Assmus, B., Urbich, C., Zeiher, A. M. and Dimmeler, S. (2000) Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arterioscler., Thromb., Vasc. Biol. 20, 402-409
80. Geng, Y. J. and Libby, P. (1995) Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 β-converting enzyme. Am. J. Pathol. 147, 251-266
81. Kolodgie, F. D., Narula, J., Burke, A. P. et al. (2000) Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157, 1259-1268
82. Salvayre, R., Auge, N., Benoist, H. and Negre-Salvayre, A. (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585, 213-221
83. Asmis, R. and Begley, J. G. (2003) Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ. Res. 92, e20-e29
84. Yao, P. M. and Tabas, I. (2001) Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J. Biol. Chem. 276, 42468-42476
85. Geng, Y. J., Phillips, J. E., Mason, R. P. and Casscells, S. W. (2003) Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. Biochem. Pharmacol. 66, 1485-1492
86. Napoli, C. and Ignarro, L. J. (2003) Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol. 43, 97-123
87. Zhang, J., Dawson, V. L., Dawson, T. M. and Snyder, S. H. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Washington, D.C.) 263, 687-689
88. Radi, R., Beckman, J. S., Bush, K. M. and Freeman, B. A. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of Superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487
89. Dimmeler, S., Haendeler, J., Galle, J. and Zeiher, A. M. (1997) Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95, 1760-1763
90. Kim, Y. M., Bombeck, C. A. and Billiar, T. R. (1999) Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84, 253-256
91. Brookes, P. S., Salinas, E. P., Darley-Usmar, K. et al. (2000) Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 275, 20474-20479
92. de Nigris, F., Lerman, L. O., Ignarro, S. W. et al. (2003) Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc. Natl. Acad. Sci. U.S.A. 100, 1420-1425
93. Delikouras, A., Hayes, M., Malde, P., Lechler, R. I. and Dorling, A. (2001) Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-α-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71, 599-605
94. Dimmeler, S., Assmus, B., Hermann, C., Haendeler, J. and Zeiher, A. M. (1998b) Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 83, 334-341
95. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R. and Zeiher, A. M. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (London) 399, 601-605
96. Buttery, L. D., Springall, D. R., Chester, A. H. et al. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75, 77-85
97. Chung, H. T., Pae, H. O., Choi, B. M., Billiar, T. R. and Kim, Y. M. (2001) Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282, 1075-1079
98. Patel, R. P., Moellering, D., Murphy-Ullrich, J., Jo, H., Beckman, J. S. and Darley-Usmar, V. M. (2000) Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radicals Biol. Med. 28, 1780-1794
99. Shichiri, M., Yokokura, M., Marumo, F. and Hirata, Y. (2000) Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler., Thromb., Vasc. Biol. 20, 989-997
100. Hendersen, E. L., Geng, Y. J., Sukhova, G. K., Whittemore, A. D., Knox, J. and Libby, P. (1999) Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99, 96-104
101. Kiener, P. A., Davis, P. M., Rankin, B. M. et al. (1997) Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159, 1594-1598
102. Ye, S., Humphries, S. and Henney, A. (1998) Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis. Clin. Sci. 94, 103-110
103. Galis, Z. S. and Khatri, J. J. (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad and the ugly. Circ. Res. 90, 251-262
104. van der Wal, A. C., Becker, A. E., van der Loos, C. M. and Das, P. K. (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44
105. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126
106. Hosono, M., de Boer, O. J., van der Wal, A. C. et al. (2003) Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 168, 73-80
107. Imanishi, T., Han, D. K., Hofstra, L. et al. (2002) Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 161, 143-151
108. Fukuo, K., Nakahashi, T., Nomura, S. et al. (1997) Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology 43, 35-42
109. Cai, W, Devaux, B., Schaper, W. and Schaper, J. (1997) The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131, 177-186
110. Geng, Y. J., Henderson, L. E., Levesque, E. B., Muszynski, M. and Libby, P. (1997) Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler., Thromb., Vasc. Biol. 17, 2200-2208
111. Richardson, B. C., Lalwani, N. D., Johnson, K. J. and Marks, R. M. (1994) Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24, 2640-2645
112. Sata, M. and Walsh, K. (1998) Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J. Biol. Chem. 273, 33103-33106
113. Sata, M. and Walsh, K. (1998) Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 102, 1682-1689
114. Sata, M., Suhara, T. and Walsh, K. (2000) Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. Arterioscler., Thromb., Vasc. Biol. 20, 309-316
115. Bennett, M., Macdonald, K., Chan, S. W., Luzio, J. P., Simari, R. and Weissberg, P. (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (Washington, D.C.) 282, 290-293
116. Kim, K. (2001) Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death. Biochem. Biophys. Res. Commun. 281, 305-310
117. Dimmeler, S., Breitschopf, K., Haendeler, J. and Zeiher, A. M. (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189, 1815-1822
118. Karsan, A., Yee, E. and Harlan, J. M. (1996) Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271, 27201-27204
119. Kockx, M. M. (1998) Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler., Thromb., Vasc. Biol. 18, 1519-1522
120. Kockx, M. M., De Meyer, G. R., Muhring, J., Jacob, W., Bult, H. and Herman, A. G. (1998) Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97, 2307-2315
121. Han, D. K., Haudenschild, C. C., Hong, M. K., Tinkle, B. T., Leon, M. B. and Liau, G. (1995) Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147, 267-277
122. Isner, J., Kearney, M., Bortman, S. and Passeri, J. (1995) Apoptosis in human atherosclerosis and restenosis. Circulation 91, 2703-2711
123. Bennett, M. R., Evan, G. I. and Schwartz, S. M. (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95, 2266-2274
124. Bennett, M. R. (1999) Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41, 361-368
125. Leskinen, M. J., Kovanen, P. T. and Lindstedt, K. A. (2003) Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells-a potential mechanism for the weakening and ening and rupture of atherosclerotic plaques. Biochem. Pharmacol. 66, 1493-1498
126. Bauriedel, G., Hutter, R., Welsch, U., Bach, R., Sievert, H. and Luderitz, B. (1999) Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41, 480-488
127. Dhume, A. S. and Agrawal, D. K. (2003) Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle and increased apoptosis in symptomatic carotid artery disease. J. Vasc. Surg. 38, 155-161
128. Dhume, A. S., Soundararajan, K., Hunter, III, W. J. and Agrawal, D. K. (2003) Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann. Vasc. Surg. 17, 1-8
129. von der Thusen, J. H., van Vlijmen, B. J., Hoeben, R. C. et al. (2002) Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105, 2064-2070
130. Vasudevan, S. S., Lopes, N. H., Seshiah, P. N. et al. (2003) Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages. Cardiovasc. Res. 59, 723-733
131. Kockx, M. M. and Herman, A. G. (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45, 736-746
132. Bombeli, T., Karsan, A., Tait, J. F. and Harian, J. M. (1997) Apoptotic vascular endothelial cells become procoagulant. Blood 89, 2429-2442
133. Mallat, Z., Hugel, B., Ohan, J., Leseche, G., Freyssinet, J. M. and Tedgui, A. (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353
134. Mallat, Z. and Tedgui, A. (2000) Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130, 947-962
135. Young, I. S. and Woodside, J. V. (2001) Antioxidants in health and disease. J. Clin. Pathol. 54, 176-186
136. Neuzil, J., Kagedal, K., Andera, L., Weber, C. and Brunk, U. T. (2002) Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7, 179-187
137. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J. and Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 154-160
138. Laufs, U., La Fata, V, Plutzky, J. and Liao, J. K. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135
139. Aviram, M., Rosenblat, M., Bisgaier, C. L. and Newton, R. S. (1998) Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 138, 271-280
140. Bellosta, S., Bernini, F., Ferri, N. et al. (1998) Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis 137 (Suppl.), S101-S109
141. Baetta, R., Donetti, E., Comparato, C. et al. (1997) Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells. Pharmacol. Res. 36, 115-121
142. Erl, W., Hristov, M., Neureuter, M., Yan, Z. Q., Hansson, G. K. and Weber, P. C. (2003) HMG-CoA reductase inhibitors induce apoptosis in neomtima-denved vascular smooth muscle cells. Atherosclerosis 169, 251-258
143. Kockx, M. M., De Meyer, G. R., Buyssens, N., Knaapen, M. W., Bult, H. and Herman, A. G. (1998) Cell composition, replication and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ. Res. 83, 378-387
144. Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J. and Nilsson, J. (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103, 926-933
145. Mueck, A. O. and Seeger, H. (2003) Statins and direct vascular actions. Panminerva Med. 45, 1-6
146. Pollman, M. J., Hall, J. L., Mann, M. J., Zhang, L. and Gibbons, G. H. (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med. 4, 222-227
147. Sata, M. and Walsh, K. (1998b) TNF α regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat. Med. 4, 415-420
148. George, S. J. (2000) Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin. Investig. Drugs. 9, 993-1007
149. George, S. J., Lloyd, C. T., Angelini, G. D., Newby, A. C. and Baker, A. H. (2000) Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101, 296-304
150. Belanger, A. J., Scaria, A., Lu, H., Sullivan, J. A., Cheng, S. H., Gregory, R. J. and Jiang, C. (2001) Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action. Cardiovasc. Res. 51, 749-761
151. Chapman, J. G., Magee, W. P., Stukenbrok, H. A., Beckius, G. E., Milici, A. J. and Tracey, W. R. (2002) A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur. J. Pharmacol. 456, 59-68
152. Guttenplan, N., Lee, C. and Frishman, W. H. (2001) Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition. Heart Dis. 3, 313-318
153. Chou, T. M., Woodburn, K. W., Cheong, W. F. et al. (2002) Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc. Interv. 57, 387-394
154. Beohar, N., Flaherty, J. D., Davidson, C. J. et al. (2004) Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 109, 108-113